Epigenomics AG
Epigenomics AG does not have significant operations. Previously, the company was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is headquartered in Heidelberg, Germany.
Market Cap & Net Worth: Epigenomics AG (EPGNF)
Epigenomics AG (PINK:EPGNF) has a market capitalization of $692.79K ($692.79K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #37521 globally and #12233 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Epigenomics AG's stock price $0.79 by its total outstanding shares 876949 (876.95K).
Epigenomics AG Market Cap History: 2015 to 2025
Epigenomics AG's market capitalization history from 2015 to 2025. Data shows change from $2.15 Million to $692.79K (-18.38% CAGR).
Epigenomics AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Epigenomics AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.29x
Epigenomics AG's market cap is 1.29 times its annual revenue
0.68x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.15 Million | $2.08 Million | -$8.98 Million | 1.03x | N/A |
| 2016 | $3.92 Million | $4.20 Million | -$11.16 Million | 0.93x | N/A |
| 2017 | $4.28 Million | $1.86 Million | -$10.23 Million | 2.30x | N/A |
| 2018 | $1.68 Million | $1.53 Million | -$12.69 Million | 1.10x | N/A |
| 2019 | $1.40 Million | $1.12 Million | -$17.02 Million | 1.25x | N/A |
| 2020 | $3.85 Million | $842.00K | -$11.69 Million | 4.57x | N/A |
| 2021 | $613.86K | $6.20 Million | -$2.43 Million | 0.10x | N/A |
| 2022 | $1.54 Million | $485.00K | -$12.02 Million | 3.18x | N/A |
| 2023 | $438.47K | $339.23K | -$4.46 Million | 1.29x | N/A |
Competitor Companies of EPGNF by Market Capitalization
Companies near Epigenomics AG in the global market cap rankings as of March 18, 2026.
Key companies related to Epigenomics AG by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #91 globally with a market cap of $176.18 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #154 globally with a market cap of $120.38 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.34 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #512 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #91 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.18 Billion | $470.00 |
| #154 | Danaher Corporation | NYSE:DHR | $120.38 Billion | $191.39 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.34 Billion | $586.37 |
| #512 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Epigenomics AG Historical Marketcap From 2015 to 2025
Between 2015 and today, Epigenomics AG's market cap moved from $2.15 Million to $ 692.79K, with a yearly change of -18.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $692.79K | 0.00% |
| 2024 | $692.79K | +58.00% |
| 2023 | $438.47K | -71.59% |
| 2022 | $1.54 Million | +151.43% |
| 2021 | $613.86K | -84.05% |
| 2020 | $3.85 Million | +174.38% |
| 2019 | $1.40 Million | -16.49% |
| 2018 | $1.68 Million | -60.74% |
| 2017 | $4.28 Million | +9.17% |
| 2016 | $3.92 Million | +82.15% |
| 2015 | $2.15 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Epigenomics AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $692.79K USD |
| MoneyControl | $692.79K USD |
| MarketWatch | $692.79K USD |
| marketcap.company | $692.79K USD |
| Reuters | $692.79K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.